Veterinary CRO And CDMO Market Report 2026

Veterinary CRO And CDMO Market Overview

• Veterinary CRO And CDMO market size has reached to $7.53 billion in 2025 • Expected to grow to $11.81 billion in 2030 at a compound annual growth rate (CAGR) of 9.6% • Growth Driver: Increasing Pet Ownership Driving The Growth Of The Veterinary CRO And CDMO Market • Market Trend: Expansion Of Integrated Multi-Site CDMO Networks To Accelerate Veterinary Drug Development And Commercializatio • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary CRO And CDMO Market?

A veterinary CRO is a specialized service provider that conducts research and clinical trials to evaluate the safety and efficacy of veterinary drugs and healthcare products, and a veterinary CDMO is a specialized service provider that offers contract development and manufacturing services for veterinary drugs and healthcare products, assisting with formulation development, process optimization, and production. The main services of veterinary CRO and CDMO are discovery, development, manufacturing, packaging and labeling, and market approval and post-marketing. Drug discovery is the process of identifying and developing new medications or therapeutic interventions to treat or prevent diseases in humans or animals. In the context of veterinary CDMO (Contract Development and Manufacturing Organization) and CMO (Contract Manufacturing Organization), drug discovery services typically refer to the early-stage research and development activities related to the identification and optimization of potential drug candidates on behalf of their clients. The veterinary CRO and CDMO services cover companion animals and livestock animals and these are used in applications such as medicines, medical devices, pharmaceuticals, biologics, and others.

What Is The Veterinary CRO And CDMO Market Growth Forecast?

The veterinary cro and cdmo market size is expected to see strong growth in the next few years. It will grow to $11.81 billion in 2030 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to increasing demand for contract research and manufacturing services, technological advancements in veterinary drug development, growth of veterinary biologics and pharmaceuticals, expansion of global regulatory compliance requirements, rising adoption of precision medicine for animals. Major trends in the forecast period include increasing outsourcing of veterinary drug development, expansion of preclinical and clinical trial services, growing demand for regulatory consulting services, adoption of advanced analytical and formulation services, rising focus on post-marketing surveillance and pharmacovigilance.

Global Veterinary CRO And CDMO Market Segmentation

1) By Service Type: Discovery, Development, Manufacturing, Packaging And Labeling, Market Approval And Post-marketing 2) By Animal Type: Companion Animals, Livestock Animals 3) By Application: Medicines, Medical Devices, Pharmaceuticals, Biologics, Other Applications Subsegments: 1) By Discovery: Target Identification, Target Validation, Lead Identification, Lead Optimization 2) By Development: Preclinical Development, Clinical Development (Phase I, II, III), Regulatory Consulting 3) By Manufacturing: API Manufacturing, Finished Dose Formulation, Analytical Services 4) By Packaging And Labeling: Primary Packaging, Secondary Packaging, Label Design And Compliance 5) By Market Approval And Post-marketing: Regulatory Submissions, Pharmacovigilance, Post-marketing Surveillance

What Is The Driver Of The Veterinary CRO And CDMO Market?

Increasing pet ownership is expected to propel the growth of the veterinary CRO and CDMO market going forward. Pet ownership is the state of being the primary person or household responsible for the care, well-being, and control of a domesticated animal. It involves a long-term, legal, and ethical commitment. Increasing pet ownership is rising due to the growing awareness of the emotional and health benefits of having pets, as people seek companionship, stress relief, and improved well-being through pet care. The veterinary CRO and CDMO market supports increasing pet ownership, as the growing number of pets drives demand for the development and manufacturing of veterinary drugs, vaccines, and treatments to ensure pet health and safety. For instance, in March 2025, according to the American Pet Products Association, a US-based non-profit association, ninety-four (94) million U.S. households own at least one pet, compared to eighty-two (82) million in 2023. Therefore, the increasing pet ownership is expected to drive the veterinary CRO and CDMO industry going forward.

Key Players In The Global Veterinary CRO And CDMO Market

Major companies operating in the veterinary cro and cdmo market are Eurofins Scientific SE, Charles River Laboratories Inc., IDEXX Laboratories Inc., Elanco India Private Limited, Aenova Group, Taconic Bioscience Inc., knoell Germany GmbH, ClinVet International Pty Ltd., VetPharm Inc., Vetio Animal Health Company, Ridgeway Research Ltd., Drayton Animal Health Ltd., KLIFOVET GmbH, Cebiphar, Veterinary Research Management (VRM) Ltd., Vetspin Srl, STATKING Animal Health CRO, Arcoblu S.r.l., Syneos Health Inc., Pharmaceutical Product Development Inc., Inotiv Inc., Promega Corporation, Triveritas Ltd.

Global Veterinary CRO And CDMO Market Trends and Insights

Major companies operating in the veterinary CRO and CDMO market are focusing on developing innovative services such as integrated multi-site CDMO networks with advanced sterile manufacturing, lyophilization, and specialized dosage capabilities to streamline drug development lifecycles and accelerate compliant commercialization pathways. Integrated multi-site CDMO networks are unified platforms that combine multiple manufacturing locations and specialized technologies including sterile multidose systems, lyophilization, and flexible packaging under harmonized operational and quality frameworks to deliver end-to-end pharmaceutical development and production services. For instance, in April 2025, Meribel Pharma Solutions, a UK-based full-service CDMO offering drug development, formulation, analytical services, sterile and semi-solid manufacturing, and packaging solutions, launched operations with a network of 13 facilities across France, Spain, and Sweden to support products from early development through commercial-scale production, providing centers of excellence in oral solid dose, preservative-free multidose, and lyophilization technologies for both human and veterinary health products.

What Are Latest Mergers And Acquisitions In The Veterinary CRO And CDMO Market?

In May 2023, Argenta, a Belgium-based contract research organization (CRO) and contract development and manufacturing organization (CDMO) company, acquired Midwest Veterinary Services Inc. for an undisclosed amount. Through this acquisition, Argenta aims to enhance the service offerings of both companies, allowing them to provide a wider array of clinical research, product development, and manufacturing solutions. Midwest Veterinary Services Inc. is a US-based firm specializing in veterinary CRO and CDMO services, focusing on the development and testing of animal health solutions.

Regional Outlook

North America was the largest region in the veterinary CRO and CDMO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary CRO And CDMO Market?

The veterinary CRO and CDMO market includes revenues earned by entities through contract research, development, and manufacturing services. This encompasses the income generated by these entities for conducting preclinical studies, clinical trials, pharmacokinetics, and pharmacodynamics testing, toxicology studies, formulation development, process optimization, and manufacturing of veterinary drugs and healthcare products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.